78/100B107.470
USD
1.49
(1.41%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Edwards Lifesciences market capWhat is market capitalization? Market cap is what the stock market values a whole company at: its share price times the number of its shares outstanding.
Edwards Lifesciences's market cap is 61.80B USD: 575,000,000 shares outstanding at today's price of 107.47.
- Today
- 61.80B
- Average, 5 years
- 50.83B
- Low, 5 years
- 35.92B
- High, 5 years
- 81.50B
Market cap = price × shares outstanding = 107.47 × 575.00M = 61.80B
Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.
Market cap by year and by quarter
| Fiscal year | Period ending | Market cap |
|---|---|---|
| Today | 61.80B | |
| FY2025 | 31 Dec 2025 | 49.85B |
| FY2024 | 31 Dec 2024 | 44.25B |
| FY2023 | 31 Dec 2023 | 46.26B |
| FY2022 | 31 Dec 2022 | 46.18B |
| FY2021 | 31 Dec 2021 | 80.75B |
| FY2020 | 31 Dec 2020 | 56.80B |
| FY2019 | 31 Dec 2019 | 48.59B |
| FY2018 | 31 Dec 2018 | 32.04B |
| FY2017 | 31 Dec 2017 | 23.77B |
| FY2016 | 31 Dec 2016 | 19.96B |
| FY2015 | 31 Dec 2015 | 17.02B |
| FY2014 | 31 Dec 2014 | 13.57B |
| FY2013 | 31 Dec 2013 | 7.35B |
| FY2012 | 31 Dec 2012 | 10.36B |
| FY2011 | 31 Dec 2011 | 8.10B |
| FY2010 | 31 Dec 2010 | 9.19B |
| FY2009 | 31 Dec 2009 | 4.89B |
| FY2008 | 31 Dec 2008 | 3.07B |
| FY2007 | 31 Dec 2007 | 2.64B |
| FY2006 | 31 Dec 2006 | 2.75B |
| FY2005 | 31 Dec 2005 | 2.48B |
| FY2004 | 31 Dec 2004 | 2.46B |
| FY2003 | 31 Dec 2003 | 1.78B |
| FY2002 | 31 Dec 2002 | 1.50B |
| FY2001 | 31 Dec 2001 | 1.63B |
| FY2000 | 31 Dec 2000 | 1.03B |
| FY1999 | 31 Dec 1999 | 958.47M |
| Quarter | Period ending | Market cap |
|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 49.75B |
| Q2 FY2026 | 30 Jun 2026 | 52.14B |
| Q1 FY2026 | 31 Mar 2026 | 46.38B |
| Q4 FY2025 | 31 Dec 2025 | 49.48B |
| Q3 FY2025 | 30 Sept 2025 | 45.47B |
| Q2 FY2025 | 30 Jun 2025 | 45.91B |
| Q1 FY2025 | 31 Mar 2025 | 42.54B |
| Q4 FY2024 | 31 Dec 2024 | 43.66B |
| Q3 FY2024 | 30 Sept 2024 | 39.41B |
| Q2 FY2024 | 30 Jun 2024 | 54.34B |
| Q1 FY2024 | 31 Mar 2024 | 56.70B |
| Q4 FY2023 | 31 Dec 2023 | 46.15B |
| Q3 FY2023 | 30 Sept 2023 | 42.05B |
| Q2 FY2023 | 30 Jun 2023 | 57.25B |
| Q1 FY2023 | 31 Mar 2023 | 50.26B |
| Q4 FY2022 | 31 Dec 2022 | 45.73B |
| Q3 FY2022 | 30 Sept 2022 | 51.21B |
| Q2 FY2022 | 30 Jun 2022 | 59.04B |
| Q1 FY2022 | 31 Mar 2022 | 73.23B |
| Q4 FY2021 | 31 Dec 2021 | 80.85B |
| Q3 FY2021 | 30 Sept 2021 | 70.60B |
| Q2 FY2021 | 30 Jun 2021 | 64.45B |
| Q1 FY2021 | 31 Mar 2021 | 52.12B |
| Q4 FY2020 | 31 Dec 2020 | 56.88B |
| Q3 FY2020 | 30 Sept 2020 | 49.66B |
| Q2 FY2020 | 30 Jun 2020 | 42.12B |
| Q1 FY2020 | 31 Mar 2020 | 39.27B |
| Q4 FY2019 | 31 Dec 2019 | 48.71B |
| Q3 FY2019 | 30 Sept 2019 | 45.79B |
| Q2 FY2019 | 30 Jun 2019 | 38.56B |
| Q1 FY2019 | 31 Mar 2019 | 39.50B |
| Q4 FY2018 | 31 Dec 2018 | 31.87B |
| Q3 FY2018 | 30 Sept 2018 | 35.70B |
| Q2 FY2018 | 30 Jun 2018 | 30.50B |
| Q1 FY2018 | 31 Mar 2018 | 29.33B |
| Q4 FY2017 | 31 Dec 2017 | 23.76B |
| Q3 FY2017 | 30 Sept 2017 | 23.10B |
| Q2 FY2017 | 30 Jun 2017 | 24.89B |
| Q1 FY2017 | 31 Mar 2017 | 19.87B |
| Q4 FY2016 | 31 Dec 2016 | 20.02B |
| Q3 FY2016 | 30 Sept 2016 | 25.70B |
| Q2 FY2016 | 30 Jun 2016 | 21.16B |
| Q1 FY2016 | 31 Mar 2016 | 18.80B |
| Q4 FY2015 | 31 Dec 2015 | 17.04B |
| Q3 FY2015 | 30 Sept 2015 | 15.30B |
| Q2 FY2015 | 30 Jun 2015 | 15.33B |
| Q1 FY2015 | 31 Mar 2015 | 15.36B |
| Q4 FY2014 | 31 Dec 2014 | 13.68B |
| Q3 FY2014 | 30 Sept 2014 | 10.87B |
| Q2 FY2014 | 30 Jun 2014 | 9.06B |
| Q1 FY2014 | 31 Mar 2014 | 7.91B |
| Q4 FY2013 | 31 Dec 2013 | 7.18B |
| Q3 FY2013 | 30 Sept 2013 | 7.73B |
| Q2 FY2013 | 30 Jun 2013 | 7.55B |
| Q1 FY2013 | 31 Mar 2013 | 9.37B |
| Q4 FY2012 | 31 Dec 2012 | 10.37B |
| Q3 FY2012 | 30 Sept 2012 | 12.47B |
| Q2 FY2012 | 30 Jun 2012 | 11.87B |
| Q1 FY2012 | 31 Mar 2012 | 8.29B |
| Q4 FY2011 | 31 Dec 2011 | 8.07B |
| Q3 FY2011 | 30 Sept 2011 | 8.17B |
| Q2 FY2011 | 30 Jun 2011 | 10.01B |
| Q1 FY2011 | 31 Mar 2011 | 10.00B |
| Q4 FY2010 | 31 Dec 2010 | 9.18B |
| Q3 FY2010 | 30 Sept 2010 | 7.62B |
| Q2 FY2010 | 30 Jun 2010 | 6.35B |
| Q1 FY2010 | 31 Mar 2010 | 5.60B |
| Q4 FY2009 | 31 Dec 2009 | 4.90B |
| Q3 FY2009 | 30 Sept 2009 | 3.94B |
| Q2 FY2009 | 30 Jun 2009 | 3.82B |
| Q1 FY2009 | 31 Mar 2009 | 3.40B |
| Q4 FY2008 | 31 Dec 2008 | 3.07B |
| Q3 FY2008 | 30 Sept 2008 | 3.23B |
| Q2 FY2008 | 30 Jun 2008 | 3.44B |
| Q1 FY2008 | 31 Mar 2008 | 2.50B |
| Q4 FY2007 | 31 Dec 2007 | 2.61B |
| Q3 FY2007 | 30 Sept 2007 | 2.83B |
| Q2 FY2007 | 30 Jun 2007 | 2.84B |
| Q1 FY2007 | 31 Mar 2007 | 2.94B |
| Q4 FY2006 | 31 Dec 2006 | 2.71B |
| Q3 FY2006 | 30 Sept 2006 | 2.71B |
| Q2 FY2006 | 30 Jun 2006 | 2.67B |
| Q1 FY2006 | 31 Mar 2006 | 2.58B |
| Q4 FY2005 | 31 Dec 2005 | 2.48B |
| Q3 FY2005 | 30 Sept 2005 | 2.66B |
| Q2 FY2005 | 30 Jun 2005 | 2.56B |
| Q1 FY2005 | 31 Mar 2005 | 2.57B |
| Q4 FY2004 | 31 Dec 2004 | 2.46B |
| Q3 FY2004 | 30 Sept 2004 | 2.00B |
| Q2 FY2004 | 30 Jun 2004 | 2.07B |
| Q1 FY2004 | 31 Mar 2004 | 1.90B |
| Q4 FY2003 | 31 Dec 2003 | 1.78B |
| Q3 FY2003 | 30 Sept 2003 | 1.60B |
| Q2 FY2003 | 30 Jun 2003 | 1.90B |
| Q1 FY2003 | 31 Mar 2003 | 1.61B |
| Q4 FY2002 | 31 Dec 2002 | 1.50B |
| Q3 FY2002 | 30 Sept 2002 | 1.50B |
| Q2 FY2002 | 30 Jun 2002 | 1.29B |
| Q1 FY2002 | 31 Mar 2002 | 1.64B |
| Q4 FY2001 | 31 Dec 2001 | 1.63B |
| Q3 FY2001 | 30 Sept 2001 | 1.37B |
| Q2 FY2001 | 30 Jun 2001 | 1.55B |
| Q1 FY2001 | 31 Mar 2001 | 1.15B |
| Q4 FY2000 | 31 Dec 2000 | 1.03B |
| Q3 FY2000 | 30 Sept 2000 | 1.27B |
| Q2 FY2000 | 30 Jun 2000 | 1.08B |
| Q1 FY2000 | 31 Mar 2000 | 787.83M |
| Q4 FY1999 | 31 Dec 1999 | 958.47M |
See also:P/E ratio,P/S ratio,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Edwards Lifesciences's market cap
Source: Financial Modeling Prep